The Cdc42‐mediated propulsive dynamic actin remodeling mechanism, combined with our report on the upregulation of proteolytic cathepsin B upon RXFP1 activation [45], establishes the CTRP8‐RXFP1 system as a powerful new promoter of GBM invasiveness. The gene discussed is CDC42; the disease is glioblastoma.